MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
MIRA Pharmaceuticals | 10-Q: Quarterly report
MIRA Pharmaceuticals | 10-K: Annual report
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shekhat Denil Nanji
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jerman Michael Allen
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Del Giudice Matthew Paul
MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Shekhat Denil Nanji
MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Del Giudice Matthew Paul
MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director MacPherson Edward Clouston
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | EFFECT: Others
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner McNulty Brian Patrick
MIRA Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brian McNulty, Individually and as Trustee of the Bay Shore Trust(31.01%),Bay Shore Trust(26.94%)
No Data